India to approve Vaccine by next week, SII submits required data: Report

New Delhi, 23/12: According to a report in Reuters, India is likely to approve Oxford/AstraZeneca’s Vaccine as the Serum Institute of India submits required data.

India could be the first country to give the regulatory approval for the British drugmaker’s vaccine. The AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates because it is cheaper, easier to transport, and can be stored for long periods at normal fridge temperatures.

India has not yet signed a vaccine supply deal with any company, but SII has already stockpiled more than 50 million doses of the AstraZeneca vaccine shots and plans to make a total of 400 million doses by July next year, as reported in indiatoday.in